Armeen Mahvash, MD

Physician
MD Anderson Cancer Center, United States

Presentation(s):

• Debate: RadSeg (glass) vs. RadSeg (resin) – Best Practices and Data

  Sunday, April 12, 2026
  8:30 AM - 8:50 AM ET

• Cases and Discussions

  Sunday, April 12, 2026
  8:50 AM - 9:00 AM ET

• DOORwaY90: Selective Internal Radiation Therapy using SIR-Spheres Y-90 Resin Microspheres as first-line treatment for unresectable Hepatocellular Carcinoma patients (NCT04736121)

  Sunday, April 12, 2026
  3:54 PM - 4:03 PM ET

• Predicting Adequate Future Liver Remnant Hypertrophy Following Liver Venous Deprivation (LVD) in Colorectal Liver Metastases: A Radiomic-Based Approach

  Monday, April 13, 2026
  3:09 PM - 3:18 PM ET

• Characterization of HCC Tumor Response Using Prospective Voxel Dosimetry in 90Y-radioembolization Clinical Trial RAPY90D

  Monday, April 13, 2026
  3:18 PM - 3:27 PM ET

• Outcomes of Resin Yttrium-90 Radioembolization with Advanced Dosimetry for Large HCC Tumors (>8cm): A Retrospective Cohort

  Tuesday, April 14, 2026
  3:36 PM - 3:45 PM ET

• Analysis of Radiation Segmentectomy Treatment Planning in DOORwaY90: Selective Internal Radiation Therapy Using SIR-Spheres Y-90 Resin Microspheres as First-line Treatment for Unresectable Hepatocellular Carcinoma Patients

  Wednesday, April 15, 2026
  11:15 AM - 11:24 AM ET